EnVVeno Medical (NVNO) Stock Highlights

3.37 | -6.65%

2024-11-21 06:07:40

enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Statistics

Range Today

3.32 3.67

Volume Today 316.3K

Range 1 Year

3.01 6.97

Volume 1 Year 26.75M

Range 3 Year

2.51 7.93

Volume 3 Year 47.17M

Range 10 Year

2.51 141

Volume 10 Year 216.11M

Highlights

Market Capitalization 61.55M (small)

Floating Shares 17.48M

Current Price 3.37

Price To Earnings -2.73

Price To Book 1.3

Earnings Per Share -1.29

Payout Ratio 0%

Performance

Latest -6.65%

1 Month -0.3%

3 Months -35.69%

6 Months -32.73%

1 Year -21.08%

3 Years -55.25%

5 Years -76.8%

10 Years -97.3%

Benchmarks

Market Capitalization

71 / 92

Gross Profits

0 / 85

Total Revenue

0 / 89

Total Rank

90 / 92

Free Cashflow

48 / 90

Performance 5 years

68 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.